[French ccAFU guidelines - Update 2018-2020: Retroperitoneal sarcoma]

Area of Science:

• Oncology
• Surgical Oncology
• Radiology

Context:

• Retroperitoneal sarcoma is a rare and aggressive malignancy.
• Accurate diagnosis and staging are critical for effective treatment planning.
• Multidisciplinary management is essential for optimizing patient outcomes.

Purpose:

• To update French urological guidelines for the diagnosis, treatment, and follow-up of retroperitoneal sarcoma.
• To provide evidence-based recommendations for managing patients with retroperitoneal sarcoma.
• To emphasize the importance of centralized care in high-volume centers.

Summary:

• Imaging (CT, MRI) is crucial for evaluating suspected retroperitoneal sarcoma.
• Biopsy via extraperitoneal coaxial percutaneous sampling is the recommended standard before treatment.
• Surgery aiming for complete tumor removal with negative margins is the cornerstone of treatment.
• Multidisciplinary team discussions are vital for weighing risks and benefits of multimodal therapy.
• Relapse rates correlate with tumor grade and surgical margins.

Impact:

• Improved patient prognosis through standardized, high-quality initial management.
• Centralization of care in specialized sarcoma networks enhances treatment efficacy.
• Updated guidelines facilitate consistent and evidence-based clinical practice in France.